DK0445781T3 - Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol - Google Patents

Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol

Info

Publication number
DK0445781T3
DK0445781T3 DK91103425.4T DK91103425T DK0445781T3 DK 0445781 T3 DK0445781 T3 DK 0445781T3 DK 91103425 T DK91103425 T DK 91103425T DK 0445781 T3 DK0445781 T3 DK 0445781T3
Authority
DK
Denmark
Prior art keywords
arylcarbonyl
aminoalkyl
indole
preparations containing
glaucoma
Prior art date
Application number
DK91103425.4T
Other languages
Danish (da)
English (en)
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of DK0445781T3 publication Critical patent/DK0445781T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK91103425.4T 1990-03-08 1991-03-06 Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol DK0445781T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (1)

Publication Number Publication Date
DK0445781T3 true DK0445781T3 (da) 1996-02-19

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103425.4T DK0445781T3 (da) 1990-03-08 1991-03-06 Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol

Country Status (21)

Country Link
EP (1) EP0445781B1 (fr)
JP (1) JP3157179B2 (fr)
KR (1) KR0183396B1 (fr)
AT (1) ATE133663T1 (fr)
AU (1) AU643757B2 (fr)
CA (1) CA2036307C (fr)
DE (1) DE69116705T2 (fr)
DK (1) DK0445781T3 (fr)
ES (1) ES2082872T3 (fr)
FI (1) FI95369C (fr)
GR (1) GR3019058T3 (fr)
HU (1) HU215125B (fr)
IE (1) IE72953B1 (fr)
IL (1) IL97426A (fr)
MX (1) MX174433B (fr)
MY (1) MY106109A (fr)
NO (1) NO179612C (fr)
NZ (1) NZ237309A (fr)
PH (1) PH27022A (fr)
PT (1) PT96938B (fr)
RU (1) RU2073670C1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
IL139203A0 (en) * 1998-05-01 2001-11-25 Lilly Co Eli Spla2 inhibitor ester
EP0985414B1 (fr) * 1998-05-26 2003-08-27 Pfizer Products Inc. Médicament pour le traitement du glaucôme et de la rétinopathie ischémique
WO2001040183A1 (fr) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1 h-indoles pour traiter le glaucome
ATE409491T1 (de) * 2000-01-18 2008-10-15 Merck & Co Inc Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension
US6653304B2 (en) 2000-02-11 2003-11-25 Bristol-Myers Squibb Co. Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
SE0203070D0 (en) 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
KR101723125B1 (ko) 2015-07-29 2017-04-04 이은솔 개선된 구조의 위생 젓가락
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
IL97426A (en) 1996-03-31
NO910868D0 (no) 1991-03-05
IL97426A0 (en) 1992-06-21
HUT56492A (en) 1991-09-30
KR0183396B1 (ko) 1999-05-01
FI95369C (fi) 1996-01-25
EP0445781A1 (fr) 1991-09-11
PT96938A (pt) 1991-10-31
MX24839A (es) 1993-10-01
RU2073670C1 (ru) 1997-02-20
FI911131A (fi) 1991-09-09
NZ237309A (en) 1993-02-25
NO179612B (no) 1996-08-05
ES2082872T3 (es) 1996-04-01
NO910868L (no) 1991-09-09
KR910016745A (ko) 1991-11-05
CA2036307A1 (fr) 1991-09-09
NO179612C (no) 1996-11-13
JP3157179B2 (ja) 2001-04-16
AU643757B2 (en) 1993-11-25
MX174433B (es) 1994-05-16
AU7266991A (en) 1991-09-12
EP0445781B1 (fr) 1996-01-31
CA2036307C (fr) 2002-07-09
IE910700A1 (en) 1991-09-11
DE69116705D1 (de) 1996-03-14
ATE133663T1 (de) 1996-02-15
GR3019058T3 (en) 1996-05-31
FI911131A0 (fi) 1991-03-06
IE72953B1 (en) 1997-05-07
MY106109A (en) 1995-03-31
PT96938B (pt) 1998-07-31
PH27022A (en) 1993-02-01
FI95369B (fi) 1995-10-13
HU215125B (hu) 1998-09-28
DE69116705T2 (de) 1996-09-26
JPH04235164A (ja) 1992-08-24

Similar Documents

Publication Publication Date Title
DK0445781T3 (da) Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol
ZA907338B (en) Thienylcarboxylates of amino alcohols
DE69010139D1 (de) Haarkräftigungsmittel.
DK0472327T3 (da) Præparat på form af øjendråber
ATE96671T1 (de) Verwendung von tetrahydrocortisol in der therapie von glaukom.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
IT1240683B (it) Composizione farmaceutica contenente egf
ATE109465T1 (de) 4-aryl-4-piperidine (oder -pyrrolidin- oder - hexahydroazepin-) carbinole und heterocyclische analoga davon.
DE59101404D1 (de) Topische Präparate.
DE3886314D1 (de) Substituierte Thieno(2,3-b) thiophen-2-sulfonamide als Mittel gegen Glaukoma.
FR2483234B2 (fr)
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
DE3767940D1 (de) Pyranderivate.